RecruitingNCT05483855

Telehealth-delivered HealthcaRe to ImproVe Care

Telehealth-delivered HealthcaRe to ImproVe Care (THRIVE) as an Integral Component of Remote Therapeutic Monitoring (RTM)


Sponsor

Attune Health Research, Inc.

Enrollment

1,580 participants

Start Date

Jan 3, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Objective 1: Evaluate patients' satisfaction with their telehealth care and determine factors associated with satisfaction. Objective 2: Deploy PROs and patient self-assessment tools, specifically a patient-facing instructional in-app tool that instructs RA patients how to perform self-assessment examinations to observe and report the number of tender and swollen joint counts.


Eligibility

Min Age: 19 Years

Inclusion Criteria3

  • Must be 19 years or older.
  • Must have a prior diagnosis of Rheumatoid Arthritis.
  • Must be able to read and write in English or Spanish.

Exclusion Criteria3

  • Younger than 19 years of age
  • Does not have a prior diagnosis of Rheumatoid Arthritis.
  • Unable to read and write in English or Spanish

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObjective 1 Only: Telehealth Satisfaction Survey

Participants must complete a telehealth satisfaction survey rating their standard of care telehealth visit on a scale of 1 to 10, with 1 denoting low satisfaction and 10 denoting high satisfaction.

OTHERObjective 2 Only: ArthritisPower Joint Assessment

RA patients must complete a self-assessment examination of their joints using the ArthritisPower app prior to their in-office visit, where a repeat joint assessment is performed by participating physician.


Locations(1)

Attune Health Research Inc

Beverly Hills, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05483855


Related Trials